Searched for
GLP 1
Nestle to cut artificial colourings from all products by end-2026Nestle is set to eliminate all artificial food colorings globally by the end of 2026, a significant move by the major food producer. This i...- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- ITC's business with BAT grows 10% to Rs 1,587 crore in FY26, but dividend payout falls 9%ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...
- Two British American Tobacco-linked entities receive Rs 3,896 crore ITC dividend in FY26British American Tobacco's Indian entities received ₹3,895.74 crore in dividends from ITC in FY26, a slight decrease from the previous year...
- IGCAR Kalpakkam Hydrogen Plant: India inaugurates world’s first hydrogen plant that uses nuclear reactor heat instead of electricityIGCAR Kalpakkam Hydrogen Plant: India has unveiled the world's first nuclear-powered hydrogen production facility at Kalpakkam, utilizing h...
- This man started growing cluster beans after losing faith in market vegetables. Today, he grows 150 varieties at homeVijay Sharma transformed a small home garden into a thriving 1,500-square-foot oasis, proving that fresh produce is accessible to all. His ...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Hormuz oil shock echoes 1973 embargo lessonsThe recent Strait of Hormuz closure, though brief, signals a potential turning point for global energy. Echoing the 1973 oil embargo, this ...
- India hands over Rs 2.5 billion cheque to Bhutan as 5th tranche towards Economic Stimulus ProgrammeIndia has disbursed the fifth tranche of Rs 250 crore for Bhutan's Economic Stimulus Programme, bringing the total released to Rs 1,250 cro...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- ITC bulking up with products rich in protein and fibre: Sanjiv Puri“India is also a protein-deficient market. We already have offerings such as high-protein atta, soya chunks and protein shakes, and we will...
- Stress, poor sleep and processed food are driving heart attacks in young Indians: Ramakanta PandaYoung Indian professionals, particularly in IT and finance, are facing a heart disease crisis due to unhealthy lifestyles. Leading cardiac ...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
- Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Weight-loss drugs trim UK food bills by $1 billionHouseholds with at least one user of GLP-1 weight-loss drugs bought 299 million fewer food items in the year after adoption of the medicati...
Load More
